×
Mar 4, 2013 · The poorer prognosis conferred by codon 12 KRAS mutations was not confirmed in other studies [22, 23]. We report a retrospective exploratory ...
Missing: q= q% 3Dhttps% 2Fmicrobialcellfactories. 2F10. 2Fs12934- 02240-
People also ask
Mar 2, 2023 · In this review, we will focus on tumour-intrinsic immune modulation through oncogenic signalling via RAS and other prominent oncogenes, and how ...
Missing: 3Dhttps% 2Fmicrobialcellfactories. 2F10. 2Fs12934- 02240-
Nov 6, 2021 · Colorectal cancer (CRC) is a heterogeneous disease at the cellular and molecular levels. Kirsten rat sarcoma (KRAS) is a commonly mutated ...
Missing: 3Dhttps% 2Fmicrobialcellfactories. 2F10. 2Fs12934- 02240-
Apr 22, 2024 · Genetic features of patients were evaluated with Next Generation Sequencing (NGS) through the Illumina NovaSeq 6000 platform and TruSigt™ ...
Missing: 3Dhttps% 3A% 2Fmicrobialcellfactories. 2F10. 2Fs12934- 02240-
Mar 27, 2024 · Colorectal cancer (CRC) frequently involves mutations in the KRAS gene, impacting therapeutic strategies and prognosis.
Missing: q= q% 3Dhttps% 3A% 2Fmicrobialcellfactories. 2F10. 2Fs12934- 02240-
Jan 27, 2023 · PRECONNECT was an international, phase IIIb trial evaluating the safety and efficacy of trifluridine/tipiracil (FTD/TPI) for metastatic ...
Missing: q= q% 3Dhttps% 2Fmicrobialcellfactories. 2F10. 2Fs12934- 02240- w
Aug 5, 2023 · The TAGS, an international joint phase III study to examine the prolongation of overall survival (OS) of FTD/TPI over placebo in patients with ...
Missing: q= q% 3Dhttps% 2Fmicrobialcellfactories. 2F10. 2Fs12934- 02240-